200 10510 design:1.14971829960161 draw:1.80971327284465 eric:4.53974238066564 figure:1.80971327284465 follow:1.02323415249249 gonna:3.55891312765391 health:1.34789522818535 lorelei:4.53974238066564 mucci:4.25206030821386 professionals:3.44113009199753 researchers:1.94947521521981 rimm:4.53974238066564 study:0.888061252106805 talk:0.42341891172476 thought:1.92478260262944
10510 19410 cohort:2.32203570971108 design:1.14971829960161 draw:1.80971327284465 eric:4.53974238066564 figure:1.80971327284465 follow:1.02323415249249 health:1.34789522818535 nested:2.93030446823154 professionals:3.44113009199753 researchers:1.94947521521981 rimm:4.53974238066564 study:0.888061252106805 talked:0.42341891172476 thought:1.92478260262944 undertook:4.53974238066564
19410 29640 advanced:3.55891312765391 cancer:1.54401010711165 case:0.325148690291958 cohort:2.32203570971108 control:0.919855798038651 design:1.14971829960161 levels:1.07400647786591 nested:2.93030446823154 prostate:3.84659520010569 researchers:1.94947521521981 risk:0.614474148487469 selenium:3.84659520010569 study:0.888061252106805 talked:0.42341891172476 undertook:4.53974238066564
29640 36700 advanced:3.55891312765391 cancer:1.54401010711165 case:0.325148690291958 control:0.919855798038651 men:2.38025813131226 follow:1.02323415249249 health:1.34789522818535 50000:3.84659520010569 levels:1.07400647786591 1986:1.36168855031769 professionals:3.44113009199753 prostate:3.84659520010569 invited:2.74798291143758 remember:0.417998844255421 risk:0.614474148487469 selenium:3.84659520010569 started:0.748005541111992 study:0.59204083473787
36700 47020 initially:1.54401010711165 men:2.38025813131226 follow:1.02323415249249 men:2.38025813131226 health:1.34789522818535 questionnaire:2.27105883934727 50000:3.84659520010569 1986:2.72337710063538 professionals:3.44113009199753 invited:2.74798291143758 remember:0.417998844255421 started:0.748005541111992 study:0.296020417368935
47020 57210 initially:3.0880202142233 men:2.38025813131226 men:2.38025813131226 free:1.44869992730732 questionnaire:2.27105883934727 started:1.66806275578162 50000:3.84659520010569 1986:4.08506565095307 cancer:3.84659520010569 invited:2.74798291143758 cancer:0.748005541111992 50000:0.296020417368935 study:1.92478260262944 men:0.485063074835967
57210 69030 source:3.55891312765391 interesting:1.68711095075232 thought:0.675510039073838 year:1.66806275578162 50000:1.36168855031769 toenails:0.834333624600489 toenails:2.54731221597543 men:0.748005541111992 started:0.59204083473787 investigators:1.92478260262944 collect:8.0578335137993 study:0.485063074835967
69030 77130 beginning:1.51122028428865 biomarkers:3.55891312765391 end:0.802072762382268 entire:1.94947521521981 grow:3.15344801954575 nail:8.50412061642772 part:1.0844777777332 reason:0.834333624600489 source:2.54731221597543 study:0.296020417368935 takes:0.859231176222216 toenails:4.02891675689965 year:0.485063074835967
77130 87530 beginning:1.51122028428865 biological:3.24045939653538 clipping:4.02891675689965 end:0.802072762382268 entire:1.94947521521981 factors:0.90215622093925 grow:3.15344801954575 happened:0.60791674794131 levels:1.07400647786591 nail:8.50412061642772 part:1.0844777777332 previous:0.867670044868081 reflect:1.49521994294221 study:0.296020417368935 takes:1.71846235244443 year:0.970126149671934
87530 97430 biological:3.24045939653538 clipping:4.02891675689965 factors:0.90215622093925 happened:0.60791674794131 levels:1.07400647786591 toenails:2.74798291143758 50000:1.36168855031769 previous:0.867670044868081 reflect:1.49521994294221 specimens:3.69244452027843 study:0.296020417368935 taking:0.859231176222216 toenail:8.0578335137993 year:0.485063074835967
97430 105590 population:0.325148690291958 nested:0.919855798038651 health:1.02323415249249 37000:1.34789522818535 toenails:2.74798291143758 50000:1.36168855031769 source:2.93030446823154 study:0.514390689930487 man:3.44113009199753 follow:2.54731221597543 specimens:3.69244452027843 professionals:0.59204083473787 toenail:8.0578335137993
105590 114280 giovannucci:3.24045939653538 case:0.325148690291958 control:0.919855798038651 1987:4.9452074887738 follow:1.02323415249249 ed:4.9452074887738 health:1.34789522818535 nested:2.93030446823154 population:0.514390689930487 professionals:3.44113009199753 source:2.54731221597543 study:0.888061252106805
114280 122890 giovannucci:3.24045939653538 hypothesis:0.244727122981384 hypothesis:3.84659520010569 1987:4.9452074887738 ed:4.9452074887738 study:2.53781363373344 1987:4.9452074887738 author:0.59204083473787
122890 132510 back:0.244727122981384 larry:7.69319040021138 hypothesis:2.53781363373344 hypothesis:9.8904149775476 trial:2.38025813131226 referred:1.17244655067916 study:1.38985942728439 clark:0.59204083473787 randomized:1.54401010711165
132510 139200 study:0.244727122981384 clark:3.84659520010569 hypothesis:1.68711095075232 1996:4.9452074887738 1996:1.26890681686672 larry:4.9452074887738 published:2.38025813131226 randomized:1.17244655067916 referred:1.38985942728439 study:0.59204083473787 back:4.02891675689965 trial:1.54401010711165
139200 147090 hypothesis:0.244727122981384 back:1.68711095075232 ed:4.9452074887738 study:1.26890681686672 wanted:0.396607654274103 measure:3.84659520010569 toenails:2.99929733971849 1996:0.296020417368935 collection:8.0578335137993 stored:0.956223442209526
147090 156820 back:0.244727122981384 collection:1.68711095075232 funds:3.84659520010569 levels:1.07400647786591 limited:1.66806275578162 measure:0.793215308548206 selenium:7.69319040021138 stored:2.99929733971849 study:0.296020417368935 toenails:8.0578335137993 wanted:0.956223442209526
156820 165550 nested:0.325148690291958 case:0.919855798038651 study:4.9452074887738 funds:3.84659520010569 levels:1.07400647786591 limited:1.66806275578162 measure:0.396607654274103 37000:1.36168855031769 undertook:2.93030446823154 selenium:3.84659520010569 study:0.59204083473787 men:4.53974238066564
165550 174130 1994:3.55891312765391 study:1.28164584264415 case:0.325148690291958 control:0.919855798038651 ed:4.9452074887738 1996:0.802072762382268 ended:1.02323415249249 nested:2.93030446823154 basically:3.84659520010569 study:0.59204083473787 undertook:4.53974238066564
174130 183460 basically:7.11782625530782 1994:1.28164584264415 prostate:3.0880202142233 cancer:0.650297380583916 ended:0.802072762382268 follow:1.02323415249249 cases:1.57791165878733 advanced:7.69319040021138 study:0.296020417368935
183460 195230 1987:3.55891312765391 cancer:3.0880202142233 cases:0.650297380583916 order:0.919855798038651 occurred:1.57791165878733 set:1.78820706762369 1994:3.84659520010569 cases:0.614474148487469 risk:0.668541369757745 sampling:1.44869992730732 undertook:0.37566448042886 select:0.296020417368935 cancer:4.53974238066564
195230 203070 case:0.325148690291958 controls:0.919855798038651 identified:1.83169217956343 1988:0.810040932031445 means:0.526366880977203 looked:1.36168855031769 number:0.153557735843091 order:1.78820706762369 remember:0.417998844255421 risk:1.22894829697494 sampling:0.668541369757745 select:1.44869992730732 set:0.75132896085772 study:0.296020417368935 undertook:4.53974238066564
203070 212740 prostate:1.54401010711165 case:0.325148690291958 selected:0.919855798038651 risk:0.87618073453599 identified:1.83169217956343 1988:0.810040932031445 means:0.526366880977203 looked:1.36168855031769 number:0.153557735843091 developing:3.84659520010569 remember:0.417998844255421 risk:1.22894829697494 time:1.44869992730732 set:0.37566448042886 cancer:0.0700101655726489
212740 223500 cancer:1.54401010711165 case:0.325148690291958 control:1.8397115960773 developing:0.87618073453599 professionals:1.02323415249249 men:1.34789522818535 37000:1.36168855031769 nested:5.86060893646308 health:3.44113009199753 prostate:3.84659520010569 risk:1.22894829697494 sampling:0.668541369757745 selected:1.44869992730732 set:0.37566448042886 toenail:3.69244452027843 study:0.59204083473787 time:0.0700101655726489 study:4.02891675689965
223500 236090 larry:3.84659520010569 find:0.634408363388287 results:2.41947884446554 researchers:0.778542264972074 professionals:1.02323415249249 study:1.76715365842585 men:1.34789522818535 found:4.9452074887738 37000:2.72337710063538 nested:2.93030446823154 health:3.44113009199753 clark:1.17244655067916 specimen:1.94947521521981 compare:0.634408363388287 toenail:3.69244452027843 follow:0.59204083473787 study:4.02891675689965 randomized:1.54401010711165
236090 247620 cancer:1.54401010711165 clark:3.84659520010569 compare:0.634408363388287 epidemiological:2.41947884446554 found:1.76715365842585 health:1.34789522818535 larry:4.9452074887738 melanoma:4.53974238066564 men:2.72337710063538 population:0.514390689930487 professionals:3.44113009199753 randomized:1.17244655067916 results:0.634408363388287 skin:3.69244452027843 source:2.54731221597543 study:0.59204083473787 men:4.02891675689965 trial:1.54401010711165
247620 257190 follow:0.325148690291958 men:0.87618073453599 years:2.04646830498498 health:1.34789522818535 selenium:1.07400647786591 toenails:0.396607654274103 33000:2.72337710063538 follow:0.153557735843091 population:0.514390689930487 professionals:3.44113009199753 measured:3.84659520010569 source:2.54731221597543 study:0.296020417368935 men:8.0578335137993 toenails:0.970126149671934
257190 267320 advanced:3.55891312765391 calculate:0.550758334101362 cancer:1.54401010711165 cases:0.325148690291958 controls:0.919855798038651 develop:0.87618073453599 follow:2.04646830498498 measure:0.396607654274103 men:1.36168855031769 number:0.153557735843091 odds:0.984394319176222 prostate:3.84659520010569 ratios:0.654748047625409 relative:2.34251780332942 risk:0.614474148487469 years:0.970126149671934
267320 274870 developing:3.55891312765391 calculate:0.550758334101362 risk:0.87618073453599 found:1.76715365842585 highest:3.15344801954575 levels:1.07400647786591 60:1.47947158597407 measure:0.396607654274103 men:1.36168855031769 odds:0.984394319176222 ratios:0.654748047625409 relative:2.34251780332942 risk:1.22894829697494 selenium:3.84659520010569 toenails:4.02891675689965
274870 284230 developing:3.55891312765391 prostate:1.54401010711165 cancer:0.634408363388287 risk:0.87618073453599 risk:0.748005541111992 found:1.76715365842585 highest:3.15344801954575 levels:2.14801295573182 estimate:0.984394319176222 60:1.47947158597407 men:3.44113009199753 men:2.72337710063538 advanced:3.84659520010569 levels:2.34251780332942 line:0.634408363388287 lower:1.22894829697494 selenium:3.84659520010569 toenails:4.02891675689965
284230 296750 cancer:1.54401010711165 chance:1.14971829960161 compared:0.634408363388287 detail:2.11199414471758 estimate:0.748005541111992 levels:1.07400647786591 line:0.984394319176222 lowest:3.44113009199753 men:1.36168855031769 paper:1.7263316639056 prostate:3.84659520010569 questions:0.520360856916991 randomized:1.17244655067916 read:1.52748080516043 relative:2.34251780332942 results:0.634408363388287 risk:0.614474148487469 talk:0.42341891172476 trial:1.54401010711165
296750 306230 authors:3.24045939653538 chance:1.14971829960161 conducted:2.54731221597543 critiquing:3.44113009199753 detail:2.11199414471758 nested:2.93030446823154 paper:1.7263316639056 questions:1.04072171383398 read:1.52748080516043 study:0.296020417368935 talk:0.42341891172476 thinking:1.83169217956343
306230 318390 authors:3.24045939653538 case:0.325148690291958 cohort:2.32203570971108 conducted:2.54731221597543 control:0.919855798038651 critiquing:3.44113009199753 cohort:2.69391569016731 nested:2.93030446823154 question:1.04072171383398 study:0.888061252106805 thinking:1.83169217956343
318390 330160 question:2.14184710786727 address:0.550758334101362 case:0.650297380583916 cohort:2.32203570971108 bit:2.4603008389858 control:0.919855798038651 sampling:1.14971829960161 researchers:1.83169217956343 cohort:2.69391569016731 complex:2.80514132527753 members:1.04072171383398 design:1.94947521521981 principles:0.614474148487469 set:0.668541369757745 risk:0.37566448042886 study:0.59204083473787
330160 337400 advanced:3.55891312765391 cancer:1.54401010711165 case:0.650297380583916 complex:2.4603008389858 control:0.919855798038651 design:1.14971829960161 identified:1.83169217956343 population:0.514390689930487 principles:2.80514132527753 prostate:3.84659520010569 researchers:1.94947521521981 risk:0.614474148487469 sampling:1.33708273951549 set:0.37566448042886 source:2.54731221597543
337400 347000 advanced:3.55891312765391 cancer:1.54401010711165 case:0.325148690291958 control:0.919855798038651 definition:1.68711095075232 discuss:1.9747930232041 population:0.514390689930487 prostate:3.84659520010569 question:0.520360856916991 risk:1.22894829697494 sampled:1.33708273951549 set:0.37566448042886 source:2.54731221597543
347000 358580 advanced:3.55891312765391 cancer:3.0880202142233 definition:1.68711095075232 diagnosed:3.33612551156324 discuss:1.9747930232041 participant:3.84956520525888 prostate:7.69319040021138 question:0.520360856916991 risk:0.614474148487469 sampling:0.668541369757745 set:0.37566448042886
358580 367760 advanced:3.55891312765391 cancer:3.0880202142233 diagnosed:5.00418826734486 1993:2.86576594709396 participant:5.77434780788832 risk:1.47947158597407 prostate:7.69319040021138 diagnosed:0.520360856916991 exclude:0.614474148487469 participant:0.37566448042886
367760 377090 potential:0.919855798038651 diagnosed:1.66806275578162 question:2.86576594709396 participant:0.153557735843091 exclude:3.84956520525888 set:1.47947158597407 1993:1.04072171383398 participant:0.614474148487469 risk:0.37566448042886
377090 386180 case:0.325148690291958 control:1.8397115960773 diagnosed:1.66806275578162 exclude:2.86576594709396 number:0.153557735843091 participant:1.92478260262944 person:0.582108863985438 potential:1.47947158597407 question:0.520360856916991
386180 394540 case:0.325148690291958 control:0.919855798038651 diagnosed:1.66806275578162 exclude:2.86576594709396 selenium:1.29454924748006 relates:0.396607654274103 person:0.582108863985438 potential:1.47947158597407 1990:1.04072171383398 question:1.28164584264415 measurement:3.84659520010569 exposure:0.296020417368935
394540 406140 categorize:2.59383223161032 exposure:2.58909849496012 measurement:0.396607654274103 oftentimes:4.9452074887738 question:0.520360856916991 relates:1.28164584264415 selenium:3.84659520010569 simply:2.59383223161032 study:0.296020417368935 things:0.209009040379305
406140 416420 case:0.325148690291958 categorize:2.59383223161032 complicated:2.59383223161032 continuous:1.49521994294221 exposure:2.58909849496012 measure:0.396607654274103 oftentimes:9.8904149775476 question:0.520360856916991 simply:2.59383223161032 yesno:4.25206030821386
416420 425640 case:0.325148690291958 continuous:1.49521994294221 divided:0.725699783597694 equal:0.462204936759917 exposure:1.29454924748006 groups:0.249282939517245 levels:1.07400647786591 measure:0.396607654274103 question:0.520360856916991 quintiles:4.53974238066564 selenium:3.84659520010569 study:0.296020417368935 window:2.38025813131226 yesno:4.25206030821386
425640 436160 years:1.70652903660942 exposure:1.29454924748006 happened:0.60791674794131 levels:1.07400647786591 measurement:0.396607654274103 reflect:3.07340531187221 reflect:2.99043988588442 selenium:7.69319040021138 window:2.38025813131226 20:0.485063074835967
436160 445830 years:1.70652903660942 study:0.778542264972074 happened:0.60791674794131 recently:1.94947521521981 influence:1.52748080516043 potential:1.66806275578162 findings:1.47947158597407 reflect:3.07340531187221 ago:1.49521994294221 interpretation:0.296020417368935 20:0.485063074835967
445830 453870 biases:2.64262239577975 concepts:1.92478260262944 core:4.25206030821386 epidemiology:1.43366204994278 exposure:1.29454924748006 findings:0.778542264972074 influence:1.94947521521981 interpretation:1.52748080516043 limitations:1.66806275578162 measurement:0.396607654274103 potential:1.47947158597407 study:0.296020417368935
453870 461980 bias:3.9495860464082 biases:2.64262239577975 concepts:1.92478260262944 concerned:2.08300660784433 core:4.25206030821386 epidemiology:1.43366204994278 exposure:2.58909849496012 finally:1.21951406153715 measurement:0.793215308548206 relate:1.28164584264415
461980 471150 bias:3.9495860464082 concerned:2.08300660784433 estimate:0.748005541111992 exposure:1.29454924748006 finally:1.21951406153715 gonna:3.55891312765391 great:2.34251780332942 influence:3.89895043043962 measurement:0.396607654274103 relative:2.34251780332942 relate:1.28164584264415 risk:0.614474148487469
471150 478990 bias:1.9747930232041 estimate:0.748005541111992 final:1.21951406153715 gonna:3.55891312765391 great:2.34251780332942 influence:3.89895043043962 potential:1.47947158597407 question:1.04072171383398 relative:2.34251780332942 relates:1.28164584264415 risk:0.614474148487469 study:0.296020417368935 subsequent:3.07340531187221 undertaken:4.53974238066564
478990 489410 clark:3.84659520010569 compare:0.634408363388287 contrast:3.3357695763397 final:1.21951406153715 larry:4.9452074887738 published:2.38025813131226 question:1.04072171383398 randomized:1.17244655067916 relates:1.28164584264415 study:0.888061252106805 subsequent:3.07340531187221 undertaken:4.53974238066564
489410 500950 secondary:1.14971829960161 risk:1.54401010711165 clark:3.84659520010569 compare:1.26881672677657 contrast:3.3357695763397 1996:1.76715365842585 larry:4.9452074887738 selenium:1.47947158597407 analysis:2.72337710063538 lower:3.84659520010569 published:2.38025813131226 randomized:2.34489310135832 60:0.614474148487469 found:4.02891675689965 randomized:3.84659520010569 study:0.59204083473787
500950 510390 secondary:1.14971829960161 risk:1.54401010711165 prostate:0.634408363388287 randomized:2.41947884446554 1996:1.76715365842585 selenium:1.47947158597407 analysis:2.72337710063538 men:2.5028604534046 lower:3.84659520010569 men:2.34489310135832 60:0.614474148487469 found:4.02891675689965 randomized:3.84659520010569 placebo:0.59204083473787 study:4.53974238066564
510390 518559 association:1.11656609228471 biomarkers:3.55891312765391 blood:1.40424816473649 epidemiological:2.41947884446554 found:1.76715365842585 inverse:2.99929733971849 levels:1.07400647786591 selenium:7.69319040021138 study:0.59204083473787 toenails:4.02891675689965 undertaken:4.53974238066564
518558 528770 advanced:3.55891312765391 ago:1.70652903660942 association:1.11656609228471 biomarkers:3.55891312765391 blood:1.40424816473649 cancer:4.63203032133495 found:1.76715365842585 institute:3.3357695763397 inverse:2.99929733971849 levels:1.07400647786591 national:2.4603008389858 prostate:7.69319040021138 risk:1.22894829697494 selenium:7.69319040021138 toenails:4.02891675689965 undertook:4.53974238066564 years:0.485063074835967
528770 538130 advanced:3.55891312765391 ago:1.70652903660942 based:1.00362568110411 cancer:3.0880202142233 institute:3.3357695763397 national:2.4603008389858 prostate:3.84659520010569 select:2.89739985461464 specifically:1.29454924748006 study:0.296020417368935 trail:4.9452074887738 trial:1.54401010711165 undertaken:4.53974238066564 undertook:4.53974238066564 years:0.485063074835967
538130 547130 agent:2.93030446823154 based:1.00362568110411 cancer:1.54401010711165 chemo:4.9452074887738 conducted:2.54731221597543 data:0.231182897873627 epidemiological:2.41947884446554 potential:1.47947158597407 preventive:2.59383223161032 prostate:3.84659520010569 select:2.89739985461464 selenium:7.69319040021138 specifically:1.29454924748006 study:0.296020417368935 thinking:1.83169217956343 trail:4.9452074887738 trial:1.54401010711165 undertaken:4.53974238066564
547130 555620 agent:2.93030446823154 cancer:3.0880202142233 chemo:4.9452074887738 conducted:2.54731221597543 data:0.231182897873627 epidemiological:2.41947884446554 35000:1.36168855031769 potential:1.47947158597407 preventive:5.18766446322064 primary:2.38025813131226 prostate:7.69319040021138 recruited:3.07340531187221 selenium:7.69319040021138 united:1.41884696415764 thinking:1.83169217956343 men:1.70652903660942
555620 567450 randomized:0.281768394661733 cancer:3.0880202142233 factorial:1.14971829960161 time:2.64262239577975 called:3.44113009199753 states:2.64262239577975 35000:1.36168855031769 prevention:2.59383223161032 primary:2.38025813131226 prostate:3.84659520010569 diagnosis:1.17244655067916 design:1.87715455364018 recruited:3.07340531187221 received:7.69319040021138 united:1.41884696415764 cancer:0.0700101655726489 men:1.70652903660942 selenium:2.99929733971849
567450 576560 average:2.1689555554664 called:0.281768394661733 design:1.14971829960161 factorial:3.44113009199753 follow:1.02323415249249 placebo:2.5028604534046 published:2.38025813131226 randomized:1.17244655067916 received:1.87715455364018 selenium:7.69319040021138 study:0.296020417368935 vitamin:5.99859467943698
576560 587100 association:1.11656609228471 average:2.1689555554664 clark:3.84659520010569 contrast:3.3357695763397 epidemiological:2.41947884446554 follow:1.02323415249249 found:1.76715365842585 larry:4.9452074887738 placebo:2.5028604534046 published:2.38025813131226 results:0.634408363388287 study:1.18408166947574 vitamin:2.99929733971849 years:0.485063074835967
587100 597810 association:1.11656609228471 cancer:1.54401010711165 clark:3.84659520010569 contrast:3.3357695763397 epidemiological:2.41947884446554 found:1.76715365842585 larry:4.9452074887738 prostate:3.84659520010569 randomization:1.17244655067916 relative:2.34251780332942 results:0.634408363388287 risk:1.22894829697494 selenium:3.84659520010569 studies:0.59204083473787
597810 605880 cancer:3.0880202142233 protective:0.96552583487184 found:1.87715455364018 104:1.76715365842585 supplementation:2.59383223161032 prostate:7.69319040021138 evidence:3.07340531187221 randomization:1.17244655067916 relative:2.34251780332942 risk:1.22894829697494 selenium:7.69319040021138 selenium:3.69244452027843
605880 614110 advantages:2.02743675668952 cancer:1.54401010711165 control:0.919855798038651 disadvantages:2.99929733971849 effect:0.96552583487184 evidence:1.87715455364018 found:1.76715365842585 guess:2.64262239577975 prevention:2.59383223161032 prostate:3.84659520010569 protective:3.07340531187221 question:0.520360856916991 randomized:1.17244655067916 selenium:3.84659520010569 supplementation:3.69244452027843
614110 623410 advantages:2.02743675668952 compared:0.634408363388287 concerned:2.08300660784433 control:0.919855798038651 disadvantages:2.99929733971849 epidemiological:2.41947884446554 explanations:2.38025813131226 guess:2.64262239577975 plausible:3.44113009199753 question:1.04072171383398 randomized:1.17244655067916 study:0.296020417368935 trial:1.54401010711165
623410 635200 bias:1.9747930232041 compared:0.634408363388287 comparison:1.9747930232041 concerned:2.08300660784433 confounding:1.36168855031769 controlled:0.919855798038651 epidemiological:4.83895768893108 explanations:2.38025813131226 exposure:1.29454924748006 interpretation:1.52748080516043 outcomes:0.654748047625409 plausible:3.44113009199753 question:0.520360856916991 randomized:1.17244655067916 study:0.888061252106805 trial:1.54401010711165
635200 644760 answers:0.538488241509547 comments:2.86576594709396 comparison:1.9747930232041 controlled:0.919855798038651 critique:3.44113009199753 epidemiological:2.41947884446554 exposure:1.29454924748006 final:1.21951406153715 forward:2.30615015915854 interpretation:1.52748080516043 logging:2.34251780332942 outcomes:0.654748047625409 post:2.86576594709396 providing:2.05483573087764 question:0.520360856916991 randomized:1.17244655067916 study:0.888061252106805 thoughts:1.92478260262944
644760 654100 answers:0.538488241509547 comments:2.86576594709396 critique:3.44113009199753 forward:2.30615015915854 letting:3.24045939653538 logging:2.34251780332942 part:1.0844777777332 post:2.86576594709396 providing:2.05483573087764 questions:0.520360856916991 thoughts:1.92478260262944
